Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-... AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. Show more
Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire SAN MATEO, Calif., Nov. 13, 2024 Five sites actively screening with multiple patients having...
Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 PR Newswire SAN MATEO, Calif., Nov. 6, 2024 SAN MATEO, Calif., Nov. 6...
Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit PR Newswire SAN MATEO, Calif., Oct. 8, 2024 SAN MATEO, Calif., Oct. 8, 2024 /PRNewswire/ -- Talphera, Inc...
Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire SAN MATEO, Calif., Sept. 5, 2024 SAN MATEO, Calif., Sept. 5, 2024 /PRNewswire/ -- Talphera...
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit PR Newswire SAN MATEO, Calif., Aug. 19, 2024 The...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1935 | -22.2413793103 | 0.87 | 0.898 | 0.6505 | 132649 | 0.67199273 | CS |
| 4 | -0.3135 | -31.6666666667 | 0.99 | 1 | 0.6505 | 63338 | 0.79316146 | CS |
| 12 | -0.2535 | -27.2580645161 | 0.93 | 1.19 | 0.6505 | 97567 | 0.9513298 | CS |
| 26 | -0.4335 | -39.0540540541 | 1.11 | 1.19 | 0.6505 | 73834 | 0.94569671 | CS |
| 52 | -0.1835 | -21.3372093023 | 0.86 | 1.61 | 0.6505 | 88839 | 1.02849921 | CS |
| 156 | -0.1835 | -21.3372093023 | 0.86 | 1.61 | 0.6505 | 88839 | 1.02849921 | CS |
| 260 | -0.1835 | -21.3372093023 | 0.86 | 1.61 | 0.6505 | 88839 | 1.02849921 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
